0001181431-12-024659.txt : 20120418
0001181431-12-024659.hdr.sgml : 20120418
20120418205118
ACCESSION NUMBER: 0001181431-12-024659
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120410
FILED AS OF DATE: 20120418
DATE AS OF CHANGE: 20120418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 12767080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584526600
MAIL ADDRESS:
STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
rrd342429.xml
FORM 4/A
X0305
4/A
2012-04-10
2012-04-12
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
4370 LA JOLLA VILLAGE DRIVE, SUITE 400
SAN DIEGO
CA
92122
1
1
0
0
President and CEO
Stock Option (Right to Buy)
0.06
2012-04-10
4
A
0
506300087
0
A
2022-04-10
Common Stock
506300087
506300087
D
This amendment is being filed solely to correct the number of derivative securities acquired and the number of derivative securities beneficially owned following the reported transaction, which were reported incorrectly in the original Form 4 due to an administrative error.
The option shall vest and become exercisable with respect to one-quarter of the underlying shares on January 19, 2013 and, with respect to the remaining shares, monthly thereafter over the next three years.
By: /s/ George F. Tidmarsh
2012-04-17